Cutaneous melanoma, the most aggressive form of skin cancer, is characterized by its accumulation of a large number of ...

Clearside Biomedical Inc. (CLSD), with a market capitalization of $78.5 million, reported its fourth-quarter 2024 earnings, with revenue significantly surpassing expectations. The company reported ...

Clearside Biomedical Inc. (CLSD), with a market capitalization of $78.5 million, reported its fourth-quarter 2024 earnings, with revenue significantly surpassing expectations. The company reported a ...

in early-stage choroidal melanoma. Bel-sar is from a novel class of virus-like drug conjugate therapies that Boston, Massachusetts-based Aura is developing for various oncology indications.

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

Bristol Myers Squibb has reported disappointing results for its checkpoint inhibitor combination Opdualag in melanoma, dashing its hopes of moving the drug earlier in the treatment pathway.

The most common areas for cancer to progress are usually the liver or lungs. Although LDH is not specific to melanoma, it can be a useful test for diagnosing or monitoring skin cancer post-surgical ...

aol.com Objective To compare the optical coherence tomography (OCT) features of acute central serous chorioretinopathy (CSC) versus neovascular age-related macular degeneration (AMD), and to determine ...

Cataract surgery in patients with advanced cognitive impairment who cannot consent for surgery: an evaluation of surgical outcomes, review of the literature and recommendations for the cataract ...